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ABSTRACT 
 
 
 
Culturing cells on planar compliant substrates produces low yield of microtissues. A 
variety of microtechnologies was introduced and developed to encapsulate cells for 
producing microtissues. However, the size control of the microcapsules is challenging to 
the current technologies for cells encapsulation. In this research, we proposed a simple 
yet efficient technique to encapsulate cells leading to the growth of microtissues. The 
technique involved with the development of a flicking system which can be applied to 
encapsulate cells in calcium alginate microbeads at different flow rates and flicking 
speed. The microbeads size increased with the flow rate but decreased with the flicking 
speed. Flicking speed of 80 rpm and flow rate of 4 µl/min was chosen to use in the cells 
encapsulation. The cells encapsulated in the microbeads at cell density of 31.9 × 10
6
 
cells/ml (HaCaT) and 94.2 × 10
6
 cells/ml (ORL-48) were cultured and observed for 
proliferation over a period of time. The microbeads had a smooth surface with spongy 
and porous surface texture in FE-SEM imaging. In nucleus (DAPI) staining, the 
encapsulated HaCaT and ORL-48 cells in microbeads grew from scatter individual cells 
to form cells aggregate and then microtissues. In live and dead cells stainings, majority 
(≈99 %) of the microtissues cultured in the calcium alginate microbeads were stained in 
green which indicated the cells were alive. Alginate lyase was used to dissolve the 
alginate shells in which, the intact microtissues was released. The microtissues obtained 
were characterised by a rough and uneven surface could be due to the extracellular 
matrix proteins adjoining the cells. The cells of microtissues were viable and able to 
proliferate and spread into 2D monolayer in replating experiment. The flicking system 
has produced microbeads with controllable size and allows the growth of microtissues. 
HaCaT and ORL-48 cells encapsulated in calcium alginate microbeads can integrate into 
microtissues after two weeks of culture.  
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ABSTRAK 
 
 
 
Pengkulturan sel pada substrat yang satah menghasilkan mikrotisu yang rendah. 
Pelbagai mikroteknologi diperkenalkan dan dibangunkan untuk merangkumi sel untuk 
menghasil mikrotisu. Namun, pada masa ini teknologi kawalan saiz mikrokapsul untuk 
sel enkapsulasi adalah mencabar. Dalam kajian ini, kami mencadangkan satu teknik 
yang mudah lagi berkesan untuk merangkumi sel untuk pertumbuhan mikrotisu yang 
mempunyai potensi dalam kegunaan penilaian ubat. Teknik yang terlibat dengan 
pembangunan sistem jentik boleh digunakan untuk merangkumi sel dalam mikromanik 
kalsium alginat pada kadar aliran dan kelajuan jentik yang berbeza. Saiz mikromanik 
meningkat dengan kadar aliran tetapi menurun dengan kelajuan jentik. 80 rpm kelajuan 
jentik dan 4 µl/min kadar aliran telah digunakan dalam pengkapsulan sel. Sel yang 
terkandung dalam mikromanik pada kepadatan sel 31.9 × 10
6 
sel/ml (HaCaT) dan 94.2 × 
10
6 
sel/ml (ORL-48) dikulturkan dan diperhatikan untuk percambahan dalam satu 
tempoh masa. Mikromanik itu mempunyai permukaan yang licin dengan tekstur yang 
lembut dan berliang dalam pengimejan FE-SEM. Dalam pewarnaan nukleus (DAPI), 
HaCaT dan ORL-48 sel yang terkandung dalam mikromanik membesar daripada 
berselerak sel individu jadi sel agregat dan kemudian membentuk mikrotisu. Dalam 
pewarnaan sel hidup dan mati, majoriti (≈99 %) mikrotisu diternak dalam mikromanik 
diwarnakan hijau yang menunjukkan sel itu masih hidup. Alginat lyase digunakan untuk 
melarutkan shell alginat untuk membebaskan mikrotisu. Mikrotisu itu mempunyai sifat 
permukaan yang kasar dan tidak rata mungkin disebabkan protein matriks ekstraselular 
bersebelahan sel. Sel mikrotisu itu masih hidup dan mampu berkembang dan merebak 
jadi ekalapis 2D dalam eksperimen pemplatan semula. Sistem jentik telah menghasilkan 
mikromanik dalam saiz dikawal untuk pertumbuhan mikrotisu. Sel HaCaT dan ORL-48 
boleh membentuk mikrotisu selepas dua minggu diternak dalam mikromanik alginat. 
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1. CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
 
1.1 Overview 
 
Microbeads or microcapsules have wide applications in biomedical engineering field 
that include drug delivery, encapsulation of biomolecules, tissue padding and tissue 
regeneration. General information concerning microbeads or microcapsules is briefly 
illustrated in the research background. The problem statement highlights the weakness 
of current methods to fabricate microbeads. Consequently, a method which is very 
simple, reliable and uses cheap materials available in the lab was introduced to generate 
microbeads. Nonetheless, this chapter also covers the objectives of the research, scope of 
research and thesis outline. 
 
1.2 Research background 
 
In the development of tissue engineering, technologies for creating living functional 
tissues in the laboratory are being developed and discovered. Tissue engineering is an 
alternative to organ transplantation, drug therapy and gene therapy [1]. Animal models 
used for drug testing and drug discovery studies are not encouraged due to ethical and 
feasibility issues. Thus, in vitro tissue models (self cultured microtissues) are actively 
used in research as an alternative for quantitative, repetitive and systematic investigation 
of drugs in order to reduce the usage of animal models. These tissue models can be used 
2 
 
 
 
for high-throughput screening of drugs and for pharmacokinetic analyses of drugs [2]. 
For example, one man was brain dead and another five people were in hospital after an 
experimental drug was administered to 90 people in a French clinical trial, as reported 
by British Broadcasting Corporation (BBC) on 15 January 2016. This incident revealed 
the vital of using alternative tissue models with more availability for experimental drug 
trial might avoid sacrifice of life. 
Various in vitro methods had been developed to culture microtissues. The most 
common method to culture microtissue is culturing cells on scaffolds of biopolymers 
that can be produced using electrospinning, salt leaching and ice particle leaching 
method [3]. With this method, the cells are scattered in the pores of the scaffolds. 
Culturing cells on a planar compliant substrate such as a hydrogel produces low yield 
and inconsistent size of microtissues. This technique is arguably because it is different 
from the actual biological microenvironment in the tissue [4]. Alternatively, microtissue 
can be cultured by using microencapsulation technique that allows a compound (cells) to 
be encapsulated inside a tiny spheroid known as microsphere or microbead, having an 
average diameter as small as one micro meter to several hundred micro meters [5]. 
Microencapsulation of cells in the calcium alginate microbeads is leading to the 
formation of microtissues (multicellular spheroids) [6, 7]. The unique advantage of this 
technique is that cell culture is performed within a 3D environment that completely 
surrounds cells and enabling the delivery of intense signals to cells from all directions 
[8]. Compared to the 2D monolayer cell culture, 3D microtissue models mimic the cell 
structural organisation in the in vivo system and the cellular microenvironment 
established in the 3D models often plays a more significant role in cellular responses to 
drugs and disease progression [2].  
 Among the previous methods, microencapsulation of cells is a promising method 
because microencapsulation leads to the formation of living microtissues which is 
suitable to be used for therapeutic tests. Microbeads or microcapsules have wide 
applications in biomedical engineering field that include drug delivery, encapsulation of 
biomolecules, tissue padding and tissue regeneration. The selection of a suitable 
encapsulating material with appropriate porosity, which can facilitate the transport of 
nutrients, proteins and drugs while blocking attack of antibodies and bacteria is critical 
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[9]. The capsule must be mechanically stable and easy to handle. These requirements 
may be fulfilled by controlling the size and thickness of the encapsulating polymer 
membrane at microscale range.  
Microcapsules are spherical particles containing a core substance with the size 
varying between 50 nm to 2 mm [10]. During the early days in the 80‟s, 
microencapsulation technologies were used for the microencapsulation of drugs and 
liquidified food [11, 12]. Later in the 90‟s, this technology was discovered with new 
application in tissue engineering [13]. In tissue engineering, microcapsules of sodium 
alginate for microencapsulation of cells have the potential for the application in 
immunoisolatory and biochemical assays [14]. Biomaterials for microencapsulation of 
cells play a major roll to determine the fate of the cells encapsulated and also the 
proliferation of cells. There are various types of materials used to produce microcapsules 
such as agarose, collagen, alginate, chitosan and gelatin [15]. Sodium alginate has been 
found suitable for biotechnology and biomedical applications mainly as a material for 
the encapsulation of different cells for biochemical processing and immunoisolatory 
while the cells can still maintain viability within the hydrogel [14]. It has been employed 
for encapsulating cells to be transplanted, since it is biocompatible both to the host and 
enclosed cells [8]. 
Some of the popular methods developed particularly for the microencapsulation 
of cells are the microfluidic device [16], emulsification [17], extrusion, electrospray 
[18], electrostatic [19-21] and airflow [22]. However, these methods are complex in 
design [23], required high voltage supply [20], post cleaning process [24] and large 
volume of reagents. The purpose of this research is to develop a novel flicking system 
that could be used to produce uniform and controllable sized of calcium alginate 
microbeads for 3D cells encapsulation. Calcium alginate was proposed to be used for 
encapsulation of cells is because this biomaterial is non-toxic, degradable and it is a 
biocompatible material approved by US Food and Drug Administration (FDA) [9, 25]. 
Under the FDA approval, calcium alginate is permitted to be an implantable material in 
the human body [9, 25]. The contribution of this study is expected to be useful for 
generating 3D cells model for studying therapeutic cytochemicals. The biochemistry 
properties of the microbeads and biophysical properties of the microtissues formed will 
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be characterised using microscopy observation, FTIR scanning, Field Emission 
Scanning Electron Microscope (FE-SEM), DAPI staining, live and dead stainings and 
3D microtissues replating. The backbone of this study is to be useful for generating the 
3D microtissues, which is identified to be relevant to drive major innovations in tissue 
engineering. 
 
1.3 Problem statement 
 
The microbeads of calcium alginate can be easily generated by extruding droplets of 
sodium alginate solution in air using a syringe and allowed to polymerised in the 
calcium chloride solution. However, the extrusion technique provided limited control 
over the size of the microbeads and usually large beads of calcium alginate in millimeter 
size were produced. Small calcium alginate beads in a few hundreds of micron are 
desirable because this range of microbeads provide higher mechanical strength, easier 
implantation, better transport of oxygen and nutrients for the cells [26]. Although 
alginate beads can be fabricated by using microfluidic approach in micron size, the 
alginate microbeads formed based on microemulsion technique were covered with oil 
film and hence, post cleaning process is required to remove the oil film before 
incubating the cells. The oil film can be sealing the gas from the cells in encapsulation. 
Strong mechanical and chemical treatments are required to remove the immiscible fluid, 
which prolongs exposure of the cells to divalent ions or solvents which may harm and 
kill the cells [27]. Other methods such as microextrusion techniques assisted by 
electrostatic field and electrospraying were shown to decrease the alginate drop size. 
However, these methods required sophisticated high power circuit to create atomization 
of alginate droplets which is dangerous with electric shock hazard [20, 28].  
Based on the literature review, a simple yet efficient technique could be 
designed and developed to address the several issues raised for current techniques of 
microencapsulation. Hence, the purpose of this study is to develop a novel flicking 
system that could be used to produce calcium alginate (Ca-Alg) microbeads for the 
microencapsulation of cells. The flicking method used by the flicking system to 
encapsulate cells is simple and highly reproducible. 
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1.4 Objectives of the research 
 
The aim of the research is the development of a flicking system for producing 3D cells 
in microbeads leading to the growth of microtissues. Four objectives were outlined to 
achieve the aim: 
 
a) To develop a flicking system to produce calcium alginate microbeads size in 
200 to 300 micron. 
b) To investigate the effects of infusion pump flow rates and flicking motor 
speed to the size of the microbeads produced. 
c) To microencapsulate cells using the developed flicking system. 
d) To characterise the biophysical properties of the 3D microtissues formed in 
calcium alginate microbeads.  
 
1.5 Scope of research 
 
This research was divided into four scopes which are: 
 
a) Design and development of a mechatronic system of microextrusion system 
with a flicking device (flicking system). 
b) Determining the syringe flow rates and flicking speed of the system to 
encapsulate cells in the appropriate microbeads size. 
c) Encapsulating human keratinocyte cell lines (HaCaT) and oral squamous cell 
carcinoma (ORL-48) cells in the calcium alginate microbeads. 
d) Monitoring the growth of the microencapsulated cells into microtissues. 
 
 
1.6 Thesis outline 
 
This thesis was divided into five chapters. Chapter 1 introduced an overview of the 
research background, problem statement, objectives of the research, scope of research 
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and thesis outline. Chapter 2 revealed the cells type, the method used in 
microencapsulation, biopolymers used for microencapsulation of cells, rationale to 
generate 3D cells, instrument utilised in the research and stainings used to characterise 
the biophysical of 3D microtissues. Chapter 3 outlined the experiment procedure of this 
research including the materials and methods used in the development of flicking 
system, experimental setup, investigating the effects of flow rates and flicking speed to 
the size of microbeads, characterising the biochemistry and surface structure of the 
microbeads, preparation for microencapsulation of cells using the developed flicking 
system and characterising the biophysical properties of the 3D microtissues formed from 
the 3D cells. Chapter 4 presented the results and discussion of the research project which 
included the functions of flicking system, assessment of the system performance, the 
effects of flow rates and flicking speed to the size of microbeads, the biochemistry and 
surface structure of the microbeads, microencapsulation of HaCaT and ORL-48 cells at 
different cell densities and the biophysical properties of the 3D microtissues. At last but 
not least, Chapter 5 delivered the conclusion, thesis contribution and recommendations 
for future work.  
  
 
 
 
2. CHAPTER 2 
 
 
 
LITERATURE REVIEWS 
 
 
 
2.1 Introduction 
 
This chapter has included the summarised information of the relevant studies on cells 
microencapsulation leading to microtissues formation in the calcium alginate 
microbeads. The literature review covered the fundamental knowledge of cell and tissue, 
microencapsulation techniques and techniques used for biophysical characterisation of 
microtissues are discussed in the following subchapters which are cell and tissue, 
extracellular matrix (ECM), cell adhesion, phases of cell growth, microencapsulation, 
different technology of microencapsulation, biopolymer used for microencapsulation of 
cells, rationale to generate 3D cells, inverted phase contrast microscopy, field emission 
scanning microscope (FE-SEM), fourier transform infrared spectroscopy (FTIR), DAPI 
staining and live/dead viability assay. 
 The sources of the literatures reviewed are journals, articles, and information 
from books and internet, which are important on identifying problems as well as give 
ideas in this research. 
 
2.2 Cell and tissue 
 
The cell is the fundamental structural, functional, and biological unit of all known living 
organisms. Cells are the smallest unit of life that can replicate freely. Cells consist 
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of cytoplasm enclosed within a membrane, which contains many biomolecules such 
as  nucleic acids and proteins [29]. Organisms can be classified as unicellular (cell and 
bacteria) or multicellular (plants and animals). Human has about 100 trillion (10
14
) cells 
while the number of cells in plants and animals varies from species to species [30]. Most 
animal and plant cells are in dimensions between 1 and 100 micrometres and only can be 
visible under the microscope [31]. The cells build the structure of body, consume 
nutrients from food, convert those nutrients into energy, and carry out specialist 
functions. Organelles are structures that perform specialised tasks within the cell. These 
organelles containing in the cytoplasm are such as pinocytotic vesicle, golgi vesicles, 
cytoskeleton, endoplasmic reticulum (ER), golgi apparatus, lysosomes, mitochondria, 
centrioles, microtubules, nucleus, nucleolus, plasma membrane and ribosomes as shown 
in Figure 2.1. 
 
Figure 2.1: The anatomy of human cell [32] 
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 Cytoplasm is a jelly-like fluid which surrounds the cell‟s organelles and nucleus. 
The cytoskeleton is a chain of long fibers that build up the cell‟s structural framework 
that has several critical functions, allowing cells to move, cell division and determining 
cell shape. In addition, cytoskeleton provides a track-like system that directs the 
movement of organelles and other substances within cells. The endoplasmic reticulum is 
responsible in molecule processing and transport to their specific destinations either 
outside or inside the cell. Nonetheless, the golgi apparatus is responsible in packaging 
molecules for export from the cell. Lysosomes destroy toxic substances and recycle 
exhausted cell parts. In addition, mitochondria provide the energy for cells to replicate 
themselves with their own genetic material. Ribosomes use the cell‟s genetic 
instructions to make proteins at the same time. Besides that, the nucleus contains most of 
the cell‟s genetic material such as RNA (ribonucleic acid) and DNA (deoxyribonucleic 
acid). The plasma membrane is the outer most layer which enclosed the cell and allows 
the transport of materials to leave and enter the cell.  
 Tissue is an assembly of cells with similar characteristics which performs a 
specific function. Different types of tissues can be found in different organs as shown in 
Figure 2.2. Organs are made of tissues that provide the various functions of organs 
required to maintain biological life. There are four basic types of tissue in human, which 
are connective, epithelial, nervous and muscular tissue. The function of connective 
tissue supports and binds with other tissues. Connective tissue cells can be found in a 
large amount of extracellular matrix (ECM). Epithelial tissue covers the body surface 
and forms the lining for most internal cavities of organs. Epithelial tissues have different 
cells shapes which are squamous, cuboidal and columnar epithelium. The main functions 
of epithelial tissue are filtration, protection secretion, and absorption of glucose from the 
lumen of the intestine. Skin is one of the organs that consist of most epithelial tissue 
which protects the body from bacteria, dirt and microbes that may be harmful.  
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Figure 2.2: Human body tissues [33] 
 
2.3 Human keratinocytes 
 
The epidermis is made of squamous epithelium that forms the protective layer of the 
skin [34]. Keratinocytes are the main cell type in the epidermis layer. Epidermis consists 
of five histologically distinct cellular layers such as stratum corneum, stratum lucidum, 
stratum granulosum, stratum spinosum and stratum basale as shown in Figure 2.3. 
Stratum spinosum is the layer with the most human keratinocytes in the epidermis. 
Human keratinocytes cell line (HaCaT) is transformed immortal keratinocyte cell line 
with abnormal chromosomes number from adult human skin that has been widely used 
for scientific research, studies of cell biology and differentiation. HaCaT cells are 
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utilised for their high capacity to proliferate and differentiate in vitro [35]. HaCaT cells 
have reduced tissue proliferation and regeneration compared to normal epidermal 
keratinocytes [36, 37]. By the addition of growth factors can stimulate the proliferation 
rate of HaCaT cells [38], the characterisation of human keratinocyte using this model 
becomes reproducible and overcome the short culture lifespan issue of normal human 
keratinocyte. Figure 2.4 shows a phase contrast photomicrograph of HaCaT cells in 
monolayer of culture. In monolayer or 2D structure, HaCaT cells are displayed with 
polygonal shape and tightly coupled to the neighbouring cells when grown into 
confluency. 
 
 
Figure 2.3: Layers of the epidermis [39] 
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Figure 2.4: Monolayer of HaCaT cells cultured in a petri dish (Scale bar: 100 µm) 
 
2.4 Oral squamous cell carcinoma cell line (ORL-48) 
 
Oral cancer is a common disease and silent killer in the developing country, especially in 
Southeast Asia country. Microtissue models of cancer cells are necessary in drug 
discovery and the cancer research. Oral squamous cell carcinoma (OSCC) cell line 
(ORL-48) was established by Cancer Research Malaysia. They are surgically explanted 
epithelial specimens obtained from untreated primary human oral carcinoma cell in the 
squamous layer of the oral cavity. These epithelial cells were genetically modified to be 
immortal and grown into monolayer with doubling times ranging between 26.4 and 40.8 
hours [40]. Figure 2.5 shows a phase contrast photomicrograph of ORL-48 cells in 
monolayer culture. In 2D structure or monolayer, ORL-48 cells are typically irregular 
elongated polygonal shape and coupled randomly with the neighbouring cells. 
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Figure 2.5: Monolayer of ORL-48 cells cultured in a petri dish 
(Scale bar: 100 µm) 
 
2.5 Extracellular matrix (ECM) and cell adhesion 
 
Extracellular matrix (ECM) is made up of polysaccharides and proteins, including 
laminins, collagens, elastins, proteoglycans and fibronectins, all secreted by the cell 
[41]. In animal cells, the ECM enclosed cells as fibrils that contact the cells [42]. Cells 
in animals are also joined directly to each other by cell adhesion proteins at the cell 
surface. In addition, ECM provides a biochemical barrier, mechanical support and a 
medium for extracellular communication that is assisted by cell adhesion proteins, 
moreover ECM provides tensile strength for tendons, compressive strength for cartilage, 
hydraulic protection for cells and elasticity to the walls of blood vessels [42].  
 Adhesion of cells to the extracellular matrix (ECM) is key to the regulation of 
cellular morphology, differentiation, proliferation, migration and survival [43]. These 
functions are necessary during tissue development, maintenance of tissue structure and 
the initiation of tissue repair. Integrins are the main receptors that moderate cell 
adhesion to the components of ECM [44, 45]. Figure 2.6(a) shows a suspension cell 
adhesion to ECM proteins via integrins and Figure 2.6(b) shows the structures of ECM 
which consist actin cytoskeleton, integrin receptors, adhesion proteins and focal 
adhesion complexes. Integrins are categorised as the heterodimers which consisted of 
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two different chains, the α (alpha) and β (beta) subunits [46]. During cell-ECM 
adhesion, the specific ligands in the ECM decide the type of α and β subunits of the 
integrins being attached by the cell [47]. There are numerous integrins exist on the cell 
membrane and they work collaboratively with the cell adhesion proteins in cell-ECM 
adhesion [48]. 
 
 
Figure 2.6: Integrin-mediated cell adhesion to the ECM. (a) Suspension cell adhere to 
the surface of ECM. (b) The structures of ECM [49] 
 
 
 
(a) 
(b) 
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2.6 Phases of cell growth 
 
A regular growth curve for cultured cells displayed a sigmoid pattern of proliferation. 
The growth phases correlative with normal cells are divided into lag phase, logarithmic 
growth phase, stationary (or plateau) phase and decline phase as shown in Figure 2.7. It 
was vital to understand the growth characteristics of the cell line because any change in 
cellular growth can represent a significant problem of the cell line and affect the 
experimental results [50]. At lag phase, the cells do not divide but adapting to the culture 
conditions and the length of this phase will depend upon the growth phase of the cell 
line at the seeding density and time of subculture. During log growth phase, the cells 
actively proliferate and exponentially increase in cell density. The cell population is 
considered to be the most viable at this phase, therefore it was recommended to assess 
cellular function at this stage. Each cell line will show different cell proliferation 
kinetics during the log phase, therefore it is the optimal phase for determining the 
population doubling time [50]. After the log phase, the cellular proliferation slows down 
due to the cell population becoming confluent at stationary phase. Ultimately, the cell 
death predominates in this death phase and there will be a reduction in the number of 
viable cells. Cell death was not due to the reduction in nutrient supplements but the 
natural path of the cellular cycle.  
 
 
 
 
 
 
 
 
 
Figure 2.7: Different phases of cell growth [50] 
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2.7 Rationale to generate 3D cells 
 
In the in vitro or two-dimensional (2D) culture, cells are tightly spread and coupled to 
the bottom surface of culture flask which is contrarily to cells that retain in-vivo [4]. The 
extracellular matrix components, cell-to-cell and cell-to-matrix interaction that are 
important for proliferation, differentiation and cellular functions in vivo are lost in the 
conventional 2D culture [51].  
Cell to cell interaction in 2D culture is mainly concentrated at the boundary of 
the flattened cells [52]. Cells grown in 2D spread involuntarily by producing limited 
amount of extracellular matrix proteins due to the contactless spreading of cells [53]. 
The spatial organisation of the cells in 2D is distorted compared with the three-
dimensional (3D) tissue in-vivo [54].  
3D cells are good models as “near-to-in vivo” systems and reveal useful insights 
from a variety of ways [54]. 3D cell model is a cost effective screening platform for drug 
development and testing, simultaneously provides a better and more realistic predictive 
value for risk and safety assessment [54].  
 A major benefit of the 3D over the 2D culture is the decrease in the gap between 
cell cultures system and the cellular physiology [54]. Several researches show that 3D 
organisation of cells reveals more novel and surprising visions into the tumorigenesis 
mechanism which could represent an integral missing component in the in vitro cancer 
studies [55].  
Thus, 3D cell culture is believed to have better similarity to the actual tissue 
model for cancer cell research because 3D culture restore specific morphological and 
biochemical features similar to the corresponding tissue in-vivo [56].  
Besides that, modelling the complexity of cancer utilising these cell lines on 
standard plastic substrate does not accurately represent the tumour microenvironment 
[57]. However, tumour cells cultured in 2D monolayer conditions do not respond to 
cancer therapeutics [57]. Thus, 3D cells culture is useful for drug testing on cancer 
tumour.  
Many researchers want to mimic the actual cancer tumour in human body by 
culturing cancer cells into 3D cells because the 3D cells reveal a more realistic drug 
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response, precisely characterises the disease and mimics the tumour microenvironment 
in human body [58]. Other than that, the applications of 3D cell are differentiation 
studies, drug discovery and pharmacological applications, cancer research, gene and 
protein expression studies [59]. 
 
2.8 Previous methods for growing 3D cells 
 
3D cells culture exhibits features that are closer to the complex in vivo conditions and 
the 3D culture models have proven to be more realistic for translating the study findings 
for in vivo applications [59].  
Various in vitro methods had been developed for growing 3D cells as shown in 
Table 2.1. While each method presents its unique factors, the appropriate method must 
be selected to meet the requirements for the specific type of cells in different 
applications.  
The most common method to culture microtissue is culturing cells in suspension 
such as hanging drop method. With this method, the cells are scattered in the suspension 
media with limited flexibility. It is not a safe to use when one is dealing with extremely 
pathogenic organisms as the user can easily get an infection. 
Matrigel, Extracel and AlgiMatrix are the common methods used to culture 3D 
microtissues on substrate. Culturing cells on a planar compliant substrate produces low 
yield and inconsistent size of microtissues.  
Other than that, microencapsulation techniques are also applied in microtissue 
culturing that allows 3D cells growing within tiny spheroid matrix. The unique 
advantage of this technique is that cell culture is performed within a 3D environment 
that completely surrounds cells, enabling the delivery of intense signals to cells from all 
directions [8]. 
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Table 2.1: Summary of 3D cell culture systems [60] 
 
3D cell culture systems 
 
Pros 
 
Cons Methods 
 
3D spheroids grown in 
suspension. 
 
 
 No added materials 
 Consistent spheroid 
formation; control 
over size 
 Co-cultures possible 
 Transparent 
 High-throughput 
screening capable; 
compatible with 
liquid handling tools 
 Inexpensive 
 
 
 
 No support or 
porosity 
 Limited flexibility 
 Size of spheroid 
limiting 
 
Magnetic cell 
levitation [4] and 
hanging drop [61] 
 
3D spheroids grown on 
matrix. 
 
 Large variety of 
natural or synthetic 
materials 
 Customisable 
 Co-cultures possible 
 Inexpensive 
 
 Gelling mechanism 
 Gel-to-gel variation 
and structural 
changes over time 
 Undefined 
constituents in 
natural gels 
 May not be 
transparent 
 High-throughput 
screening options 
limited 
 
 
 
Hydrogel [3], 
Matrigel, Extracel 
and AlgiMatrix [62] 
 
3D spheroid grown 
within matrix. 
 
 
 
 Large variety of 
materials possible 
for desired 
properties 
 Customisable 
 Co-cultures possible 
 Medium cost 
 
 Possible scaffold-to-
scaffold variation 
 May not be 
transparent 
 Cell removal may be 
difficult 
 High-throughput 
screening options 
limited 
 
 
 
Microencapsulations 
[5, 7] 
 
 
 
Culture media 
3D spheroid 
Culture media 
3D spheroid 
 
Matrix 
 
Matrix 
 
3D spheroid 
 
Culture media 
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2.9 Microencapsulation 
 
Vincenzo Bisceglie was the first to encapsulate cells using polymer membranes in 1933 
[63]. Based on Bisceglie‟s work, Thomas Chang proposed the idea of encapsulating 
cells within ultra thin polymer membrane microcapsules to provide immunoprotection to 
the cells and introduced the term "artificial cells" to define this concept of 
bioencapsulation in 1964 [64]. Microcapsule, microsphere or microbead are similar 
terms that is defined as a spherical particle containing a core substance with a size 
between 50 nm to 2 mm [10]. However, microcapsules may not be spherical structurally 
but are referred to empty particles made of hydrogel (Figure 2.8). Many researches were 
worked on microspheres and microcapsules for the applications of controlled drug 
release formulations. They have been proven suitable for many applications which can 
be produced from natural or synthetic materials, but they are usually found in nature, for 
example, microencapsulation is also a natural phenomenon as what we can observe in 
the bacterial spores, plants seeds and egg shells [65]. 
 Microcapsules are divided into three categories that are determined by the 
structure and layers of encapsulation. Mononuclear or single-core (Type A) is the 
simplest form of microcapsules. The core material of mononuclear microcapsules 
usually is a liquid, thus they can be called as liquid-core microcapsules also which is 
surrounded by a layer of membrane [66]. The diameter of the core material and the 
membrane thickness can vary in size. Multi-shells (Type B) microcapsules have multiple 
shell layers which modify the original permeability and stability characteristics of the 
microcapsules [67]. Polynuclear or multi-core (Type C) microcapsules containing two or 
more individual cores [68]. Microcapsules of Type A-C are normally looked like 
spherically shaped particles with a well-defined shell and core structure but other non-
spherical forms of microcapsules are categorised as Type D and Type E of 
microcapsules. Type D microcapsule is the most common type of microcapsules without 
multilayer of membrane applied for encapsulation of cells, particles and does not possess 
multiple layer of membrane. We always referred these microcapsules as microbeads or 
microspheres [69]. In addition, Type E are non-spherical or irregular shaped 
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microcapsules that can be polynuclear, mononuclear or solid particle encapsulation and 
they are commonly used in the pharmaceutical and food industry [70]. 
 
Figure 2.8: The five main structural forms of microcapsules [65] 
 
 The microencapsulation technology has been applied to biotechnological and 
medical disciplines recently such as the encapsulation of mammalian cells [71], 
implantation of cells [72] and encapsulation of recombinant therapeutic proteins [73]. 
There are six main applications of microencapsulation within a membrane compared to 
its non-encapsulated form as shown in Table 2.2 with the examples of where the process 
was implemented.  
 
 
 
 
 
 
A. Single-core B. Multi-shell C. Multi-core 
D. Entrapment E. Irregular 
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Table 2.2: Application of encapsulation and target of encapsulation [65] [65] 
 
Application of encapsulation Target of encapsulation 
Protection or stabilization of the encapsulant from 
interactions with reactive environments or future 
surroundings 
 Cells (Prevention) 
 Mammalian (immuno-response and cell damage 
due to agitation and aeration) 
 Yeast (ethanol toxicity) 
 Enzymes 
 Improved stability and reactivity 
 Prevent denaturing 
 Food additives and bioactives 
 Off-setting loss and deterioration by: 
 High temperature food processing 
 passage through the GI tract 
 hygroscopicity 
 evaporation (aroma compounds) 
 oxidation 
 Recombinant proteins 
 Improved stability and protection 
Sustained, controlled or timed release of the core 
material 
 Agrochemicals (delivery of fertilizers, repellents, 
herbicides, fungicides, etc.) 
 Folic acid (controlled release) 
 Pharmaceuticals (controlled delivery) 
 Antibody (sustained release) 
 Adhesive (dispensed upon pressure) 
 Butan-1-ol flavour (delayed release) 
 Fragrances (dispensed upon pressure) 
Targeting of encapsulated compounds to specific 
sites 
 DNA to phagocytic cells 
 Vitamin C (oral route) 
 Probiotic bacteria (intestine) 
 Doxycycline for localized treatment of septic 
arthritis 
Enabling core material to be used as an extraction 
device for product removal including in situ 
product recovery 
 Environmental pollutants 
 Extraction of pharmaceuticals, 
herbicides/pesticides and heavy metals from water 
 In situ product recovery 
 Culture environments 
 Recovery of primary and secondary metabolites 
 Bioconversion processes 
 Removal of products from hydrolysis of Penicillin 
G and a lipase-catalysed reaction 
Improved flow properties of the encapsulant for 
enhanced handling, usage and storage including 
safety 
 Pesticides (enhanced safety handlng and usage) 
 Biosorbents (improved usage and storage) 
 Enzyme (better storage) 
 Bioactives (enhanced handling and storage) 
 Hydrophobic liquids (new applicability) 
Improved organoleptic properties of the 
encapsulation product 
 Shark liver oil (preventing undesirable taste) 
 Tea bags (improved appearance) 
 Antibiotic colistin (hiding taste) 
 Ultra Rice (preventing undesirable appearance 
and taste) 
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2.10 Different methods of microencapsulation 
 
2.10.1 Simple dripping 
 
Calcium alginate beads can be easily generated by extruding drops [74] of sodium 
alginate solution in the air using a syringe and collecting the droplets of sodium alginate 
into calcium chloride solution, it offers little control over drop formation and large 
calcium alginate beads in millimeter size were produced as shown in Figure 2.9. 
 
 
Figure 2.9: Calcium alginate beads formation by simple dripping 
 
2.10.2 Microfluidic 
 
Microfluidic device can be used to produce small calcium alginate microbeads in a few 
hundred micron size (nanometric size is also possible) with the aid of dispersion oil to 
disperse the alginate solution into small droplets as shown in Figure 2.10. Although this 
method produced smaller alginate drops, the precise control over the gelation process is 
complicated and the removal of the immiscible fluid (oil) requires strong chemical and 
mechanical treatments, which prolongs exposure of the cells to solvents which will be a 
threat to the cells [27]. 
Alginate droplet 
Calcium chloride 
solution 
Calcium alginate 
bead 
Syringe 
Alginate solution 
Syringe needle 
23 
 
 
 
 
Figure 2.10: Calcium alginate microbeads formation by microfluidic device 
 
2.10.3 Electrostatic  
 
Alternatively, microbeads generation techniques assisted by electrostatic field and 
electrospray could decrease the size of the alginate droplets as shown in Figure 2.18. In 
this method, the high voltage (up to 25 kV) of electricity in either static or pulse is used 
to create the electrostatic potential between the needle and the hardening bath (calcium 
chloride) in order to disperse the alginate solution into small droplets [20, 28]. This 
method is able to produce smaller microbeads (≥ 50 μm in diameter) under sterile 
conditions with uniform size and shape under reproducible conditions compared to 
normal dripping method [75]. 
 
Figure 2.11: Calcium alginate microbeads formation by electrostatic 
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2.10.4 Vibration technique 
 
The vibration technique is the most sophisticated dropping technique for 
microencapsulation. Vibration nozzle was used to produce alginate beads with 
immobilised proteins [76]. The vibration technique used mechanical vibrations 
generated by speaker to break up a jet of cell-alginate mixture into uniform droplets as 
shown in Figure 2.12. The calcium alginate bead size is controlled by varying the jet 
velocity, vibration frequency and jet diameter [76]. The main disadvantage of vibrating 
technique is low production yields of small microbeads, as it only produce a single 
droplet, one after another at once. The production flow rate is mainly dependent on the 
nozzle diameter with increasing diameter resulting in higher production rate, however 
the production rate is still low for the largest nozzle diameter [75]. 
  
Figure 2.12: Apparatus for producing calcium alginate beads by the vibration method, 
comprising a syringe pump for forcing sodium alginate solution from a syringe, a 
loudspeaker, and a sine wave sound generator [76] 
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